eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2019
vol. 14
 
Share:
Share:
abstract:
Review paper

Inflammatory bowel disease – one entity with many molecular faces

Sylwia Szymańska
1
,
Malgorzata Matuszczyk
2
,
Magdalena Osuch
3
,
Monika Meglicka
2
,
Edyta Szymanska
2
,
Joanna Bierła
1
,
Jaroslaw Kierkuś
2

1.
Department of Pathology, The Children’s Memorial Health Institute, Warsaw, Poland
2.
Department of Gastroenterology, Hepatology, Feeding Disorders, and Paediatrics, The Children’s Memorial Health Institute, Warsaw, Poland
3.
Medical Department, Bristol-Myers Squibb, Warsaw, Poland
Gastroenterology Rev 2019; 14 (4): 228–232
Online publish date: 2019/12/20
View full text Get citation
 
PlumX metrics:
Inflammatory bowel disease (IBD) is a heterogenous group of chronic inflammations in the gastrointestinal tract, which traditionally consists of two types: Crohn’s disease and ulcerative colitis. They differ when it comes to clinical, endoscopic, and histopathological changes. The exact aetiology of IBD has not been fully comprehended, but what is known so far is that the aetiopathogenesis of the disease is compound. Many articles have been written on the cellular/molecular background of IBD. Based on various molecular pathways, new forms of the disease have been discovered, including very early-onset IBD (VEO-IBD) or IBD coexisting with primary sclerosing cholangitis. The aim of this article is to present the molecular mechanisms leading to IBD, focusing on new forms of this disorder.
keywords:

inflammatory bowel disease, Crohn’s disease, ulcerative colitis, genetics, molecular pathways

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.